Cargando…

Hepatocellular Carcinoma in Asia: A Challenging Situation

Amongst the primary tumors of the liver, hepatocellular carcinoma (HCC) is the most common. It is also one of the most prevalent types of cancers in Asia. Mostly, HCC occurs on a background of chronic liver disease and liver cirrhosis; however, de novo HCCs can also arise in apparently normal lookin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jafri, Wasim, Kamran, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969322/
https://www.ncbi.nlm.nih.gov/pubmed/31988864
http://dx.doi.org/10.5005/jp-journals-10018-1292
_version_ 1783489305351553024
author Jafri, Wasim
Kamran, Muhammad
author_facet Jafri, Wasim
Kamran, Muhammad
author_sort Jafri, Wasim
collection PubMed
description Amongst the primary tumors of the liver, hepatocellular carcinoma (HCC) is the most common. It is also one of the most prevalent types of cancers in Asia. Mostly, HCC occurs on a background of chronic liver disease and liver cirrhosis; however, de novo HCCs can also arise in apparently normal looking livers on imaging. There are multiple risk factors for HCC, including hepatitis B and C infections, diabetes mellitus, alcohol, and nonalcoholic steatohepatitis. Other common risk factors which are known to be involved in the pathogenesis of HCC are obesity, food contaminated with aflatoxin and hemochromatosis. Many of these factors are commonly found in this part of the world, hence the high burden of disease. Besides these, smoking and familial predisposition to HCC also seem to have an important role to play in its development. Majority of HCC are missed at an early stage despite the emphasis on adequate screening and surveillance strategies. Therefore, most of the time these tumors are diagnosed at a fairly advanced stage, when palliative treatment is the only therapeutic option left. Hence, prevention of HCC by controlling and minimizing the possible risk factors is the need of the hour. How to cite this article: Jafri W, Kamran M. Hepatocellular Carcinoma in Asia: A Challenging Situation. Euroasian J Hepatogastroenterol 2019; 9(1):27-33.
format Online
Article
Text
id pubmed-6969322
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-69693222020-01-27 Hepatocellular Carcinoma in Asia: A Challenging Situation Jafri, Wasim Kamran, Muhammad Euroasian J Hepatogastroenterol Review Article Amongst the primary tumors of the liver, hepatocellular carcinoma (HCC) is the most common. It is also one of the most prevalent types of cancers in Asia. Mostly, HCC occurs on a background of chronic liver disease and liver cirrhosis; however, de novo HCCs can also arise in apparently normal looking livers on imaging. There are multiple risk factors for HCC, including hepatitis B and C infections, diabetes mellitus, alcohol, and nonalcoholic steatohepatitis. Other common risk factors which are known to be involved in the pathogenesis of HCC are obesity, food contaminated with aflatoxin and hemochromatosis. Many of these factors are commonly found in this part of the world, hence the high burden of disease. Besides these, smoking and familial predisposition to HCC also seem to have an important role to play in its development. Majority of HCC are missed at an early stage despite the emphasis on adequate screening and surveillance strategies. Therefore, most of the time these tumors are diagnosed at a fairly advanced stage, when palliative treatment is the only therapeutic option left. Hence, prevention of HCC by controlling and minimizing the possible risk factors is the need of the hour. How to cite this article: Jafri W, Kamran M. Hepatocellular Carcinoma in Asia: A Challenging Situation. Euroasian J Hepatogastroenterol 2019; 9(1):27-33. Jaypee Brothers Medical Publishers 2019 /pmc/articles/PMC6969322/ /pubmed/31988864 http://dx.doi.org/10.5005/jp-journals-10018-1292 Text en Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd. © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review Article
Jafri, Wasim
Kamran, Muhammad
Hepatocellular Carcinoma in Asia: A Challenging Situation
title Hepatocellular Carcinoma in Asia: A Challenging Situation
title_full Hepatocellular Carcinoma in Asia: A Challenging Situation
title_fullStr Hepatocellular Carcinoma in Asia: A Challenging Situation
title_full_unstemmed Hepatocellular Carcinoma in Asia: A Challenging Situation
title_short Hepatocellular Carcinoma in Asia: A Challenging Situation
title_sort hepatocellular carcinoma in asia: a challenging situation
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969322/
https://www.ncbi.nlm.nih.gov/pubmed/31988864
http://dx.doi.org/10.5005/jp-journals-10018-1292
work_keys_str_mv AT jafriwasim hepatocellularcarcinomainasiaachallengingsituation
AT kamranmuhammad hepatocellularcarcinomainasiaachallengingsituation